Cargando…
A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2
Cancer remains one of the leading causes of death worldwide. Cancer stem cells (CSCs) are the underlying reason for tumor recurrence, progression, and therapeutic resistance. Aptamers are synthetic single-stranded oligonucleotides that can specifically bind to various molecular targets. Here, we aim...
Autores principales: | Wu, Yi-Ying, Hsieh, I-Shan, Tung, Chia-Hao, Weng, Chen-Hsun, Wu, Jia-En, Yu, Jau-Song, Hong, Tse-Ming, Chen, Yuh-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829491/ https://www.ncbi.nlm.nih.gov/pubmed/35211356 http://dx.doi.org/10.1016/j.omtn.2022.01.012 |
Ejemplares similares
-
A DNA Aptamer Targeting Galectin-1 as a Novel Immunotherapeutic Strategy for Lung Cancer
por: Tsai, Yao-Tsung, et al.
Publicado: (2019) -
Annexin A1 exerts renoprotective effects in experimental crescentic glomerulonephritis
por: Labes, Robert, et al.
Publicado: (2022) -
Screening of Aptamers on Microfluidic Systems for Clinical Applications
por: Weng, Chen-Hsun, et al.
Publicado: (2012) -
Annexin A1 exerts analgesic effect in a mouse model of medication overuse headache
por: Gong, Zihua, et al.
Publicado: (2023) -
Annexin A5 Binds to Lipopolysaccharide and Reduces Its Endotoxin Activity
por: Rand, Jacob H., et al.
Publicado: (2012)